Published in
Elsevier, Journal of Thoracic Oncology, 9(12), p. 1357-1367
DOI: 10.1016/j.jtho.2017.07.005
Links
Tools
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC)
Journal article published in 2017 by
Byoung Chul Cho 
,
Dong-Wan Kim,
Alessandra Bearz,
Scott A. Laurie ,
Mark McKeage,
Gloria Borra,
Keunchil Park,
Sang-We Kim,
Marwan Ghosn,
Andrea Ardizzoni,
Evaristo Maiello,
Alastair Greystoke ,
Richard Yu,
Karen Osborne,
Wen Gu
and other authors.
,
Dong-Wan Kim,
Alessandra Bearz,
Scott A. Laurie ,
Mark McKeage,
Gloria Borra,
Keunchil Park,
Sang-We Kim,
Marwan Ghosn,
Andrea Ardizzoni,
Evaristo Maiello,
Alastair Greystoke ,
Richard Yu,
Karen Osborne,
Wen Gu
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 